Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 25, 2017
Signs of Facial Aging in Men in a Diverse, Multinational Study: Timing and Preventive BehaviorsAnthony M Rossi, Joseph Eviatar, Jeremy B Green, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 19, 2023
Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept TherapyRodolfo V Curiel, William Nguyen, Gulnara Mamyrova, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 29, 2016
Bimatoprost 0.03% for the Treatment of Eyebrow HypotrichosisJean Carruthers, Kenneth Beer, Alastair Carruthers, et al.
Journal of Drugs in Dermatology : JDD|September 7, 2021
A Randomized, Comparator-Controlled Study of HARC for Cheek Augmentation and Correction of Midface Contour DeficienciesDerek Jones, Leslie Baumann, Amir Moradi, et al.
Aesthetic Surgery Journal|June 22, 2023
Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat ReductionSachin M Shridharani, Steven Dayan, Brian Biesman, et al.
Journal of Cosmetic Dermatology|August 26, 2023
Decades of beauty: Achieving aesthetic goals throughout the lifespanJoel L Cohen, Greg J Goodman, Ada Trindade De Almeida, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 6, 2013
Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown linesAlastair Carruthers, Jean Carruthers, William P Coleman, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 9, 2014
Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trialMarion Moers-Carpi, Jean Carruthers, Steven Fagien, et al.
Plastic and Reconstructive Surgery|April 19, 2024
Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Platysma Prominence: A Randomized Phase 2 Dose-Ranging StudyRod J Rohrich, Vince Bertucci, Steven Dayan, et al.
Pageof 17